GFPT1 deficiency in muscle leads to myasthenia and myopathy in mice

Abstract. Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the rate-limiting enzyme in the hexosamine biosynthetic pathway which yields precursors requ

Saved in:
Bibliographic Details
Main Authors: Issop, Yasmin (Author) , Hathazi, Denisa (Author) , Khan, Muzamil Majid (Author) , Rudolf, Rüdiger (Author) , Weis, Joachim (Author) , Spendiff, Sally (Author) , Slater, Clarke R. (Author) , Roos, Andreas (Author) , Lochmüller, Hanns (Author)
Format: Article (Journal)
Language:English
Published: 14 June 2018
In: Human molecular genetics
Year: 2018, Volume: 27, Issue: 18, Pages: 3218-3232
ISSN:1460-2083
DOI:10.1093/hmg/ddy225
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1093/hmg/ddy225
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/hmg/article/27/18/3218/5037908
Get full text
Author Notes:Yasmin Issop, Denisa Hathazi, Muzamil Majid Khan, Rüdiger Rudolf, Joachim Weis, Sally Spendiff, Clarke R. Slater, Andreas Roos and Hanns Lochmüller
Description
Summary:Abstract. Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the rate-limiting enzyme in the hexosamine biosynthetic pathway which yields precursors requ
Item Description:Gesehen am 15.04.2020
Physical Description:Online Resource
ISSN:1460-2083
DOI:10.1093/hmg/ddy225